NewsHealth Weight loss drug GLP-1 may have potential to treat depression, improve motivation, study suggests The blockbuster GLP-1 drugs taken by many Americans for diabetes and to aid in weight loss may also have potential for treating major depression, a new study finds
Together, these nutrients help maintain healthy glutathione (GSH) levels and enhance the bodys overall antioxidant defense system
It opens the door for Indian drugmakers to launch lower-priced generic versions
The latest International Diabetes Federation (IDF) report indicates a 10.5% prevalence of T2DM in adults in 2021, projected to reach 12.2% by 2045 (Sun et al., 2022
Some compounded tirzepatide formulations even include B12but these are not FDA-regulated and carry potential risks
However, patients who maintain strict nutrition and activity protocols during weaning retain 40-75% of their weight loss at 12 months